Literature DB >> 10991671

Influence of neurotoxins and oxidative stress on the onset and progression of Parkinson's disease.

P Foley1, P Riederer.   

Abstract

It is generally accepted that progressive, irreversible and regionally specific neurodegeneration and the presence of Lewy bodies are the essential pathological hallmarks of idiopathic parkinsonism. The causes of these phenomena, however, remain to be elucidated. One of the leading hypotheses is that oxidative stress induced by reactive oxygen species (ROS), such as the hydroxyl radical, damages essential components of the neuron, resulting ultimately in cell death. Observations in the parkinsonian brain at post-mortem support this hypothesis; for example, widespread oxidative protein modification is evident. There are several potential sources of increased oxidative stress in Parkinson's disease, including mitochondrial dysfunction, increased free iron levels and impaired free radical defence mechanisms. Further, it is possible that glial, rather than neuronal, elements are primarily responsible for the initial increase in oxidative stress in the substantia nigra. It is likely that parkinsonism is the result of aberrations at multiple levels of neuronal function. Oxidative stress is no doubt one of the events involved in neurodegeneration, but is unlikely to be the initiating event. It is to be expected that the search for this event will continue for many years.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10991671     DOI: 10.1007/pl00007766

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  26 in total

1.  Distinct role for microglia in rotenone-induced degeneration of dopaminergic neurons.

Authors:  Hui-Ming Gao; Jau-Shyong Hong; Wanqin Zhang; Bin Liu
Journal:  J Neurosci       Date:  2002-02-01       Impact factor: 6.167

2.  Real-time monitoring of superoxide generation and cytotoxicity in neuroblastoma mitochondria induced by 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline.

Authors:  Sarah Jayne Boulton; Paul C Keane; Christopher M Morris; Calum J McNeil; Philip Manning
Journal:  Redox Rep       Date:  2012-05-30       Impact factor: 4.412

3.  Oxidative and non-oxidative mechanisms of neuronal cell death and apoptosis by L-3,4-dihydroxyphenylalanine (L-DOPA) and dopamine.

Authors:  R Pedrosa; P Soares-da-Silva
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

4.  The neuroprotective potential of sinapic acid in the 6-hydroxydopamine-induced hemi-parkinsonian rat.

Authors:  Kobra Zare; Akram Eidi; Mehrdad Roghani; Ali Haeri Rohani
Journal:  Metab Brain Dis       Date:  2014-08-16       Impact factor: 3.584

Review 5.  Why is nitric oxide important for our brain?

Authors:  Eleonora Džoljić; Ivan Grbatinić; Vladimir Kostić
Journal:  Funct Neurol       Date:  2015 Jul-Sep

Review 6.  Target- and mechanism-based therapeutics for neurodegenerative diseases: strength in numbers.

Authors:  Paul C Trippier; Kristin Jansen Labby; Dustin D Hawker; Jan J Mataka; Richard B Silverman
Journal:  J Med Chem       Date:  2013-03-27       Impact factor: 7.446

7.  Carnosine exerts neuroprotective effect against 6-hydroxydopamine toxicity in hemiparkinsonian rat.

Authors:  Siamak Afshin-Majd; Mohsen Khalili; Mehrdad Roghani; Narges Mehranmehr; Tourandokht Baluchnejadmojarad
Journal:  Mol Neurobiol       Date:  2014-06-18       Impact factor: 5.590

8.  The neuroprotective functions of selenoprotein M and its role in cytosolic calcium regulation.

Authors:  Mariclair A Reeves; Frederick P Bellinger; Marla J Berry
Journal:  Antioxid Redox Signal       Date:  2010-04-01       Impact factor: 8.401

9.  Cytotoxicity of dopaminochrome in the mesencephalic cell line, MN9D, is dependent upon oxidative stress.

Authors:  Andrew J Linsenbardt; Gerald H Wilken; Thomas C Westfall; Heather Macarthur
Journal:  Neurotoxicology       Date:  2009-07-18       Impact factor: 4.294

10.  Ectopic localization of FOXO3a protein in Lewy bodies in Lewy body dementia and Parkinson's disease.

Authors:  Bo Su; Haihua Liu; Xinglong Wang; Shu G Chen; Sandra L Siedlak; Eisaku Kondo; Raymond Choi; Atsushi Takeda; Rudy J Castellani; George Perry; Mark A Smith; Xiongwei Zhu; Hyoung-Gon Lee
Journal:  Mol Neurodegener       Date:  2009-07-23       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.